F(eNO)-based asthma management results in faster improvement of airway hyperresponsiveness

Asthma is characterised by inflammation and respiratory symptoms. Current asthma treatment is based on severity of asthma symptoms only. Exhaled nitric oxide fraction (F(eNO)) is not recommended by the Global Initiative for Asthma guidelines. The aim was to compare the usefulness of a F(eNO) guided...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernholm, Katrine Feldballe, Homøe, Anne-Sophie, Meteran, Howraman, Jensen, Camilla Bjørn, Porsbjerg, Celeste, Backer, Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168761/
https://www.ncbi.nlm.nih.gov/pubmed/30302333
http://dx.doi.org/10.1183/23120541.00147-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168761/
https://www.ncbi.nlm.nih.gov/pubmed/30302333
http://dx.doi.org/10.1183/23120541.00147-2017

Ejemplares similares